NIH Center for Advancing Translational Sciences: Transparency and Early Planning Are Key in Increasing Efficiency of Gene Therapy Development for Rare Diseases
February 27, 2026
February 27, 2026
BETHESDA, Maryland, Feb. 27 (TNSjou) -- The U.S. Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences issued the following news:
* * *
Transparency and Early Planning Are Key in Increasing Efficiency of Gene Therapy Development for Rare Diseases
PaVe-GT scientists underscore strategy, framework and early interaction with the FDA to align preclinical and clinical efforts in AAV gene therap . . .
* * *
Transparency and Early Planning Are Key in Increasing Efficiency of Gene Therapy Development for Rare Diseases
PaVe-GT scientists underscore strategy, framework and early interaction with the FDA to align preclinical and clinical efforts in AAV gene therap . . .